{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T05:59:58Z","timestamp":1697867998313},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":9207,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1983,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>To investigate a possible association between the \u03b2\u2010cells and the cells secreting pancreatic polypeptide (PP), the response of PP to insulin\u2010induced hypoglycaemia was investigated in seven insulin\u2010dependent diabetics with and seven without residual \u03b2\u2010cell function, all without signs of autonomic neuropathy. The mean concentrations of PP was significantly greater from 15 to 60 min after symptoms of hypoglycaemia in patients with residual \u03b2\u2010cell function than in patients without (<jats:italic>P<\/jats:italic> &lt; 0\u00b705) despite similar blood glucose concentrations in the two groups. Also the total integrated areas beneath the response curves as well as the incremental integrated areas were significantly greater in patients with \u03b2\u2010cell function (216 + 36 pmol\/l \u00d7 min and 188 \u00b1 34 pmol\/l X min, respectively) than in patients without \u03b2\u2010cell function (125 \u00b1 26 pmol\/1 \u00d7 min and 102 \u00b1 26 pmol\/l \u00d7 min) (<jats:italic>P<\/jats:italic> &lt; 0\u00b705 for both). The mean maximal concentrations of adrenaline (1\u00b153 \u00b1 0\u00b728 ng\/ml v. 1\u00b729 \u00b1 0\u00b712 ng\/ml) and noradrenaline (0\u00b756 \u00b1 0\u00b716 ng\/ml v. 0\u00b745 \u00b1 0\u00b704 ng\/ml) were not statistically different in the two groups. No well established explanation for an association between residual insulin secretion and capacity for PP\u2010response to hypoglycaemia in type 1 diabetics exists.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1983.tb03183.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:57:59Z","timestamp":1205758679000},"page":"31-36","source":"Crossref","is-referenced-by-count":3,"title":["RESPONSE OF PANCREATIC POLYPEPTIDE TO HYPOGLYCAEMIA IN INSULIN\u2010DEPENDENT DIABETICS WITH AND WITHOUT RESIDUAL \u03b2\u2010CELL FUNCTION"],"prefix":"10.1111","volume":"18","author":[{"given":"T.","family":"KRARUP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"MADSBAD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"HILSTED","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"CHRISTENSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"SESTOFT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.W.","family":"SCHWARTZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91762-7"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-6-1183"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0450163"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.26.1.53"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.26.7.605"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1515\/bchm2.1976.357.1.751"},{"key":"e_1_2_1_8_1","first-page":"205","article-title":"The glucagon\/C\u2010peptide test in the evaluation of beta\u2010cell function","volume":"468","author":"Faber O.K.","year":"1978","journal-title":"Excerpta Medica International Congress Series"},{"key":"e_1_2_1_9_1","first-page":"519","article-title":"A newly recognized pancreatic polypeptide; Plasma levels in health and disease","volume":"33","author":"Floyd J.C.","year":"1977","journal-title":"Recent Progress in Hormone Research"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00996324"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-105-6-1469"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1979.tb06069.x"},{"key":"e_1_2_1_13_1","first-page":"237","article-title":"Sensibilit\u00e9 vibratoire chez les diabetiques","volume":"6","author":"Jersild M.","year":"1957","journal-title":"Diabete"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6204.1544"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-50-3-445"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.9.772"},{"key":"e_1_2_1_17_1","first-page":"A921","article-title":"Pancreatic hormone release in Chagas' disease and the Shy\u2010Drager syndrome","volume":"20","author":"Long R.G.","year":"1979","journal-title":"Gut"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6200.1257"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2192"},{"key":"e_1_2_1_20_1","first-page":"196","article-title":"Beta\u2010cell function and metabolic control in insulin treated diabetics","volume":"93","author":"Madsbad S.","year":"1980","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.26.1.36"},{"key":"e_1_2_1_22_1","first-page":"499A","article-title":"Autonomic control of somatostatin and pancreatic polypeptide secretion by the isolated perfused canine pancreas","volume":"25","author":"Samols E.","year":"1977","journal-title":"Clinical Research"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01506150"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91349-1"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108992"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90065-9"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(80)90242-5"},{"key":"e_1_2_1_28_1","first-page":"307","article-title":"Effect of alloxan on rat pancreatic polypeptide (PP) cells","volume":"178","author":"Sundler F.","year":"1977","journal-title":"Cell Tissue Research"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.28.1.35"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1983.tb03183.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1983.tb03183.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:24:58Z","timestamp":1697685898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1983.tb03183.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983,1]]}},"alternative-id":["10.1111\/j.1365-2265.1983.tb03183.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1983.tb03183.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,1]]}}}